title: Crystal structure of an antidiabetic agent, (+/-)-5-[4-(6-hydroxy-2,5,7,8-tetramethylchroman-2-ylmethoxy)benzyl]-2,4-dioxothiazollidine, troglitazone dihydrate.
authors: Process Development Laboratories, Sankyo Co. Ltd, Hiratsuka, Kanagawa, Japan.
authors: K
authors: K
authors: Kobayashi
authors: H
authors: H
authors: Fukuhara
authors: T
authors: T
authors: Hata
mesh_terms: D002839:Chromans / Q000737:chemistry*; D003460:Crystallization; D018360:Crystallography, X-Ray; D007004:Hypoglycemic Agents / Q000737:chemistry*; D013237:Stereoisomerism; D013844:Thiazoles / Q000737:chemistry*; D045162:Thiazolidinediones; D000077288:Troglitazone
chemical_list: C458441:5-(4-(6-hydroxy-2,5,7,8-tetramethylchroman-2-ylmethoxy)benzyl)-2,4-dioxothiazollidine, troglitazone dihydrate; D002839:Chromans; D007004:Hypoglycemic Agents; D013844:Thiazoles; D045162:Thiazolidinediones; D000077288:Troglitazone